LHC Group (NASDAQ:LHCG)‘s stock had its “buy” rating restated by analysts at Royal Bank Of Canada in a report issued on Tuesday. They currently have a $69.00 price objective on the health services provider’s stock. Royal Bank Of Canada’s price target would suggest a potential upside of 7.41% from the company’s previous close.

A number of other equities research analysts have also commented on the stock. Jefferies Group LLC upped their price objective on shares of LHC Group from $56.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, May 15th. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $68.00 price objective (up from $55.00) on shares of LHC Group in a research note on Monday, May 8th. Zacks Investment Research raised shares of LHC Group from a “hold” rating to a “buy” rating and set a $59.00 price objective on the stock in a research note on Wednesday, April 19th. Benchmark Co. upped their price objective on shares of LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, June 8th. Finally, BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $64.38.

LHC Group (NASDAQ LHCG) traded down 0.84% during midday trading on Tuesday, reaching $63.70. 54,295 shares of the company’s stock traded hands. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35. The stock’s 50 day moving average price is $63.33 and its 200 day moving average price is $53.11. The firm has a market cap of $1.16 billion, a price-to-earnings ratio of 29.49 and a beta of 0.80.

COPYRIGHT VIOLATION WARNING: “Royal Bank Of Canada Reaffirms “Buy” Rating for LHC Group (LHCG)” was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/07/18/royal-bank-of-canada-reaffirms-buy-rating-for-lhc-group-lhcg-2.html.

In related news, Director Coliseum Capital Management, L sold 14,450 shares of the business’s stock in a transaction on Friday, June 16th. The shares were sold at an average price of $65.69, for a total transaction of $949,220.50. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Donald Dwayne Stelly sold 3,181 shares of the business’s stock in a transaction on Thursday, June 8th. The shares were sold at an average price of $64.97, for a total transaction of $206,669.57. Following the transaction, the chief operating officer now owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. Insiders have sold a total of 682,839 shares of company stock worth $42,140,531 in the last quarter. 14.80% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. bought a new position in LHC Group during the fourth quarter worth about $1,535,000. Comerica Bank increased its position in LHC Group by 5.8% in the fourth quarter. Comerica Bank now owns 15,836 shares of the health services provider’s stock worth $732,000 after buying an additional 863 shares during the last quarter. State Street Corp increased its position in LHC Group by 7.8% in the fourth quarter. State Street Corp now owns 373,936 shares of the health services provider’s stock worth $17,094,000 after buying an additional 26,915 shares during the last quarter. Thrivent Financial for Lutherans increased its position in LHC Group by 5.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 8,050 shares of the health services provider’s stock worth $368,000 after buying an additional 450 shares during the last quarter. Finally, Norges Bank bought a new position in LHC Group during the fourth quarter worth about $7,913,000. Institutional investors own 84.56% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.